Related Experiment Videos
T cell cytokine responses to cartilage aggrecan in BALB/c mice
H I McKee1, M G Warnock, C Laycock
1Department of Medicine (Rheumatology), Medical School, University of Newcastle Upon Tyne, UK.
Biochemical Society Transactions
|May 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Outcome of active disease in ankylosing spondylitis: a prospective study.
Musculoskeletal care·2009
Disease and psychological status in ankylosing spondylitis.
Rheumatology (Oxford, England)·2006
Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication.
Rheumatology (Oxford, England)·2004
Health problems following Campylobacter jejuni enteritis in a Lancashire population.
Rheumatology (Oxford, England)·2003
Evidence for loss of heterozygosity of 5q in sporadic haemangiomas: are somatic mutations involved in haemangioma formation?
Journal of clinical pathology·2001
Functional analysis of the molecular factors controlling Qa1-mediated protection of target cells from NK lysis.
Journal of immunology (Baltimore, Md. : 1950)·2001
One adaptor, multiple outcomes: decoding TRIFosome heterogeneity.
Biochemical Society transactions·2026
HELQ & Hel308: ancient enzymes of DNA repair and recombination.
Biochemical Society transactions·2026
Nuclear envelope rupture and resealing: mechanisms, consequences, and disease implications.
Biochemical Society transactions·2026
Unmasking programmed cell death in rhinovirus-driven asthma pathology.
Biochemical Society transactions·2026
Exploring the antifungal activity of the wheat microbiome.
Biochemical Society transactions·2026
The role of IRF5 as an immune regulator.
Biochemical Society transactions·2026
Cancer immunoediting in the melanoma tumor microenvironment: from immune elimination to therapeutic resistance.
Frontiers in immunology·2026
Lymph node lymphatic PD-L1 regulates tumor-infiltrating T cells in immune checkpoint-sensitive melanoma.
Cancer research communications·2026
Breast cancer immunogenicity as a spectrum: evolving concepts and therapeutic implications.
The Journal of clinical investigation·2026